Search

Your search keyword '"Perrin, Richard J."' showing total 701 results

Search Constraints

Start Over You searched for: Author "Perrin, Richard J." Remove constraint Author: "Perrin, Richard J."
701 results on '"Perrin, Richard J."'

Search Results

1. Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment

2. Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease

3. Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traits

4. A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function

5. Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease

6. Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

7. Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research Center

8. Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue

9. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease

10. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer’s disease

11. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

12. Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis

13. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

14. The status of digital pathology and associated infrastructure within Alzheimer’s Disease Centers

15. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

16. Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4

17. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

18. CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease

19. γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

20. Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy.

21. Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease

22. Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer’s Disease

23. Genome-wide association study and functional validation implicates JADE1 in tauopathy

24. Detection of emerging neurodegeneration using Bayesian linear mixed-effect modeling

25. Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

26. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

27. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study

28. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)

29. Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

30. Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease

32. Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers

33. Genome-wide association study and functional validation implicates JADE1 in tauopathy

34. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

35. The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives

36. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease

37. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

38. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease

39. Covariance-based vs. correlation-based functional connectivity dissociates healthy aging from Alzheimer disease

40. CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease

42. Identification of differentially expressed genes in post‐mortem tissue from African American Alzheimer disease cases and controls.

43. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study

45. Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease

47. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease

48. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders

49. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

50. The Alzheimer's Disease Neuroimaging Initiative Neuropathology Core: An update.

Catalog

Books, media, physical & digital resources